Doxorubicina e paclitaxel versus 5-fluorouracile, doxorubicina e ciclofosfamide come trattamento di prima linea in donne affette da carcinoma mammario metastatico: risultati finali di uno studio multicentrico randomizzato di fase III.

Translated title of the contribution: Doxorubicin and paclitaxel versus 5-fluorouracil, doxorubicin and cyclophosphamide as first-line treatment in women with metastatic breast carcinoma: final results of a phase III multicenter randomized trial

D. Amadori, M. Fabbri

Research output: Contribution to journalArticle

Translated title of the contributionDoxorubicin and paclitaxel versus 5-fluorouracil, doxorubicin and cyclophosphamide as first-line treatment in women with metastatic breast carcinoma: final results of a phase III multicenter randomized trial
Original languageItalian
JournalTumori
Volume87
Issue number5
Publication statusPublished - Sep 2001

ASJC Scopus subject areas

  • Cancer Research

Cite this